I think the best part of watching a rocket launch is not the countdown or roar, but the few seconds of silence when everyone waits to see whether it worked.
Looking at Rocket Lab (RKLB) today, I think the market has spent months sitting in that silence.
On Nov. 18, during the “Mad Money” Lightning Round, a caller said Peter Beck is a great CEO, and Neutron is a huge driver of the stock.
I’m drawn to the rocket business, which means I like SpaceX. But you know what, I would take this. Rocket Lab has gotten too cheap.
Then came the warning: “I think you have a good one. It’s a spec!”
For context, RKLB closed at $50.99 on Oct. 20, according to Yahoo Finance. At that point, it was down 26.91% year to date and about 59% over six months, though still up 16.90% over one year and 1,111.16% over three.
Repeated delays to its Neutron rocket, heavy share dilution to fund a major acquisition, widening near-term losses, and valuation resets have driven that recent drop, even as its core revenue and order backlog have grown.
Also Read: Jim Cramer says it’s a ‘great opportunity to sell’ RKLB stock
A Rocket Lab milestone that arrived just before the call
Cramer’s comment came days after Rocket Lab hit 100 electron launches, on a Nov. 14 mission for Japanese customer iQPS.
SpaceNews reported that it reached that mark faster than any other commercial rocket. The Motley Fool reported 96 successes in 100 launches and 21 launches so far in 2026, matching all of 2025.
“The next 100 Electrons are already booked, so we’re only accelerating from here,” Beck said in the company’s announcement.
More Jim Cramer:
-
Jim Cramer has a new warning for investors watching Anthropic
-
Jim Cramer just sent a strong warning about the Anthropic IPO
I covered this stock in October when Cramer called Neutron’s delay “a great opportunity to sell.” The stock was at $53 then, traded to a low of $43 in early November before recovering to the 50s.
His tone has now flipped. That is not unusual because I have seen another call from him on RKLB.
On April 27, Cramer called Rocket Lab “a winner,” and we saw it rally from a close of $82 that day to $151 exactly a month after.
Rocket Lab’s record quarter behind the “cheap” argument
Rocket Lab’s Q3 results, released Nov. 9, show why Cramer sees a gap between the business and the price. Revenue hit a record $268 million, up 73%. Backlog reached about $3.6 billion, up 52% from the end of Q2.
The company signed more than $515 million in new Neutron launch contracts and generated positive GAAP operating cash flow of $7.2 million. Q4 revenue is guided to $270 million to $290 million.